In conclusion, most, but not all, of the adverse metabolic effects of diet-induced obesity brought about by inhibition of 5αR1 with dutasteride can be reversed by liver-selective GR antagonism. The gene discussed is NR3C1; the disease is obesity due to melanocortin 4 receptor deficiency.